Clinical Gastroenterology and Hepatology
Volume 7, Issue 10 , Pages 1130-1137, October 2009

Reactivation of Hepatitis B With Reappearance of Hepatitis B Surface Antigen After Chemotherapy and Immunosuppression

  • Tara N. Palmore

      Affiliations

    • National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
    • Corresponding Author InformationReprint requests Address requests for reprints to: Tara N. Palmore, MD, National Institute of Allergy and Infectious Diseases, NIH, 10 Center Drive, MSC 1888, Bethesda, Maryland 20892-1888. fax: (301) 496-7383
    • ,
  • Neeral L. Shah

      Affiliations

    • University of Virginia Health System, Charlottesville, Virginia
    • ,
  • Rohit Loomba

      Affiliations

    • University of California at San Diego, San Diego, California
    • ,
  • Brian B. Borg

      Affiliations

    • Washington University, St Louis, Missouri
    • ,
  • Uri Lopatin

      Affiliations

    • Roche Pharmaceuticals, Nutley, New Jersey
    • ,
  • Jordan J. Feld

      Affiliations

    • University of Toronto, Toronto, Ontario, Canada
    • ,
  • Farooq Khokhar

      Affiliations

    • Chambersburg Gastroenterology Associates, LTD, Chambersburg, Pennsylvania
    • ,
  • Glen Lutchman

      Affiliations

    • Stanford University, Palo Alto, California
    • ,
  • David E. Kleiner

      Affiliations

    • National Cancer Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Neal S. Young

      Affiliations

    • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • Richard Childs

      Affiliations

    • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • A. John Barrett

      Affiliations

    • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland
    • ,
  • T. Jake Liang

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • ,
  • Jay H. Hoofnagle

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
    • ,
  • Theo Heller

      Affiliations

    • National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

published online 03 July 2009.

Full Text Available

  • Purchase this article for  31.50 USD

    Access is available for 24 hours.

    (Login or Register to purchase)

  • Subscribe to this title
  • Claim access now

    Current subscribers


    •  Conflicts of interest The authors disclose the following: Dr Uri Lopatin runs the HBV translational medicine program at Roche Pharmaceuticals. He made his contributions to the manuscript 3 years ago, when he was an NIH fellow. The remaining authors disclose no conflicts.

     Funding This research was supported by the Intramural Research Programs of the NIDDK (Z01 DK054514-02), NIAID, NHLBI, and NCI, NIH.

    PII: S1542-3565(09)00600-4

    doi:10.1016/j.cgh.2009.06.027

    Clinical Gastroenterology and Hepatology
    Volume 7, Issue 10 , Pages 1130-1137, October 2009